Leo Pharma’s study show calcipotriene, betamethasone dipropionate foam reduces relapses
Leo Pharma on Monday presented new results from the PSO-LONG clinical trial, the first to provide long-term maintenance data for…
Pharmaceuticals, Biotechnology and Life Sciences
Leo Pharma on Monday presented new results from the PSO-LONG clinical trial, the first to provide long-term maintenance data for…
PCR Biosystems, the UK-based PCR experts, has launched qPCRBIO Probe 1-Step Virus Detect, a high-concentration 4x RT-qPCR kit designed specifically for ultra-sensitive, high-throughput detection of viral RNA sequences, including SARS-CoV-2.
Lonza and the Swedish company Cellink have partnered to offer a comprehensive 3-dimensional (3D) bioprinting solution designed to optimize and increase access to complete 3D cell culture workflows.
Faller Packaging has published its sustainability report for 2019. Under the title “New values for a successful collaboration”, the specialist company for pharmaceutical packaging looks back on a very successful business year and shows how economic, ecological and social responsibility go hand in hand in a company.
Cell-Easy, a start-up based in Toulouse specialized in stem cell therapy, has signed an agreement with the University Hospital Centre in Toulouse, and secured the authorization to open a pharmaceutical manufacturing plant dedicated to the production of stem cells – a first in France.
In the absence of ‘in person’ meetings, access to deep dive pharma insights are not on hold, and later this month experts will discuss how AI is rapidly evolving supply chain dynamics in a ground-breaking Pharmapack Europe webinar (June 17, 2020).
New subcutaneous, fixed-dose formulation of daratumumab reduces treatment time from hours to minutes, with comparable efficacy and fewer infusion-related reactions1,2…
Mereo BioPharma on Thursday announced the completion of a $70 million (£56 million) private placement (the “Fundraising”) with a number of new and existing U.S based institutional and accredited investors.
Eurofins Technologies (Paris:ERF) announces the launch of a serology-based total antibody (IgG, IgA and IgM) detection ELISA assay for indirect diagnostic of past exposure to COVID-19.
Awards program underscores the importance of critical clinical research to deepen understanding of pulmonary disease to help improve patient outcomes…